* At a dose of 1 mg given as a single daily administration during controlled trials, the incidence of side effects was comparable to that observed with placebo. 

 
* At a dose of 2 mg per day of rilmenidine, controlled comparative studies versus [[clonidine]] (0.15 to 0.30 mg/day) or alpha2-[[methyldopa]] (500 to 1000 mg/day) demonstrated that the incidence of side effects was significantly lower with rilmenidine than with either clonidine or a-methyldopa. 

 


 
Side-effects are rare, non-severe, and transient at therapeutic doses: [[asthenia]], palpitations, insomnia, drowsiness, fatigue on exercise, epigastric pain, dryness of the mouth, diarrhea, skin rash; and exceptionally, cold extremities, postural hypotension, sexual disorders, anxiety, depression, pruritus, edema, cramps, nausea, constipation, hot flushes.

 

